Maximum effective volume of 0.25% ropivacaine for preventing hemidiaphragmatic paralysis in 90% of patients undergoing shoulder arthroscopy: a biased coin up-and-down sequential allocation trial for ultrasound-guided superior trunk block
Abstract Background Compared to interscalene block (ISB), the superior trunk block (STB) lowers the incidence of hemidiaphragmatic paralysis (HDP) without compromising analgesic efficacy, making it a valuable alternative. However, the lack of consensus on the optimal local anesthetic (LA) dose for S...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Anesthesiology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12871-025-03273-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Abstract Background Compared to interscalene block (ISB), the superior trunk block (STB) lowers the incidence of hemidiaphragmatic paralysis (HDP) without compromising analgesic efficacy, making it a valuable alternative. However, the lack of consensus on the optimal local anesthetic (LA) dose for STB limits its standardized clinical application. This study employed a dose-finding protocol to determine the maximum effective volume of 0.25% ropivacaine required to prevent HDP in 90% of patients (MEV90) undergoing shoulder arthroscopy with ultrasound-guided STB. Methods A biased coin design was used for volume assignment. All patients except the first one received a LA volume determined by the response observed in the immediately preceding participant. In case of “failure” (defined as the presence of HDP after STB), the subsequent patient received a lower volume (2 mL less than the previous dose). In case of “success” (absence of HDP), subsequent patients were randomly allocated to received either: (1) an increased volume (2 ml higher than the previous dose) with an 11% probability, or (2) the same volume with an 89% probability. Results The study cohort comprised 52 patients indicated for shoulder arthroscopy finally. Using isotonic regression with bootstrapped confidence intervals (CIs), the MEV90 of 0.25% ropivacaine for ultrasound-guided STB was estimated at 7.6 mL (95% CI: 6.5–8.5 mL). Conclusions The MEV90 of 0.25% ropivacaine for ultrasound-guided superior trunk block to prevent hemidiaphragmatic paralysis was 7.6 mL. Trial registration Chinese Clinical Trial Registry (ChiCTR2200059042); first registered 23/04/2022. |
|---|---|
| ISSN: | 1471-2253 |